Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartame.

Elmore, Susan A; Rehg, Jerold E; Schoeb, Trenton R; Everitt, Jeffrey I; Bolon, Brad

Elmore, Susan A; Rehg, Jerold E; Schoeb, Trenton R; Everitt, Jeffrey I; Bolon, Brad.

Afiliación

Elmore SA; ElmorePathology, LLC, Chapel Hill, NC, USA. Electronic address: elmorepathology@gmail.com.
Rehg JE; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Schoeb TR; Department of Genetics and Animal Resources Program, University of Alabama at Birmingham, Birmingham, AL, USA.
Everitt JI; Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
Bolon B; GEMpath, Inc., Longmont, CO, USA.

Food Chem Toxicol ; 171: 113504, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36414169

Asunto(s)

Aspartame; Neoplasias; Animales; Femenino; Embarazo; Humanos; Roedores; Patólogos; Edulcorantes; Carcinógenos; Carcinogénesis; Bioensayo/métodos

Palabras clave

Aspartame; Carcinogenicity risk assessment; Hazard identification; Hematolymphoid tumors; Mycoplasma pulmonis; Ramazzini Institute

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aspartame / Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals / Female / Humans / Pregnancy Idioma: En Revista: Food Chem Toxicol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google